Drug profile · INN
basiliximab
SIMULECT
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
basiliximab (SIMULECT) is an FDA-listed pharmaceutical active ingredient. Route of administration: single-use. Current US regulatory status: approved.
Key facts
INN basiliximab
Brand SIMULECT
Route SINGLE-USE
Formulation VIAL
ATC code L04AC02
Frequently asked questions
What is basiliximab?
basiliximab (SIMULECT) is an FDA-listed pharmaceutical active ingredient. Route of administration: single-use. Current US regulatory status: approved.
What is the brand name for basiliximab?
SIMULECT is a marketed brand name for basiliximab. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of basiliximab?
basiliximab has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.